Monopar Therapeutics Future Growth
Future criteria checks 0/6
Monopar Therapeutics is forecast to grow earnings and revenue by 18.3% and 69.1% per annum respectively while EPS is expected to grow by 23.8% per annum.
Key information
18.3%
Earnings growth rate
23.8%
EPS growth rate
| Biotechs earnings growth | 24.0% |
| Revenue growth rate | 69.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 11 Apr 2024 |
Recent future growth updates
Recent updates
Is Monopar Therapeutics (NASDAQ:MNPR) In A Good Position To Deliver On Growth Plans?
Feb 27
Will Monopar Therapeutics (NASDAQ:MNPR) Spend Its Cash Wisely?
Mar 02We Think Monopar Therapeutics (NASDAQ:MNPR) Needs To Drive Business Growth Carefully
Nov 16Monopar stock soars 19% as enrollment finishes in phase 2 part of oral mucositis study of Validive
Oct 05We're Keeping An Eye On Monopar Therapeutics' (NASDAQ:MNPR) Cash Burn Rate
Jul 30Monopar Therapeutics (NASDAQ:MNPR) Is In A Good Position To Deliver On Growth Plans
Mar 28We're Hopeful That Monopar Therapeutics (NASDAQ:MNPR) Will Use Its Cash Wisely
Jul 15Here's Why We're Not Too Worried About Monopar Therapeutics' (NASDAQ:MNPR) Cash Burn Situation
Mar 26Monopar nabs U.S. patent covering camsirubicin
Dec 22Monopar Therapeutics selects targeted immuno-therapeutic candidate for COVID-19
Dec 10Monopar launches validive mid-stage study in chemo-induced oral mucositis
Dec 08Monopar Therapeutics EPS beats by $0.02
Nov 12Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -10 | N/A | N/A | 3 |
| 12/31/2025 | N/A | -11 | N/A | N/A | 3 |
| 12/31/2024 | N/A | -10 | N/A | N/A | 3 |
| 12/31/2023 | N/A | -8 | -8 | -8 | N/A |
| 9/30/2023 | N/A | -9 | -8 | -8 | N/A |
| 6/30/2023 | N/A | -10 | -8 | -8 | N/A |
| 3/31/2023 | N/A | -10 | -7 | -7 | N/A |
| 12/31/2022 | N/A | -11 | -7 | -7 | N/A |
| 9/30/2022 | N/A | -10 | -8 | -8 | N/A |
| 6/30/2022 | N/A | -10 | -8 | -8 | N/A |
| 3/31/2022 | N/A | -10 | -8 | -8 | N/A |
| 12/31/2021 | N/A | -9 | -7 | -7 | N/A |
| 9/30/2021 | N/A | -9 | -7 | -7 | N/A |
| 6/30/2021 | N/A | -8 | -6 | -6 | N/A |
| 3/31/2021 | N/A | -7 | -5 | -5 | N/A |
| 12/31/2020 | N/A | -6 | -5 | -5 | N/A |
| 9/30/2020 | N/A | -5 | -4 | -4 | N/A |
| 6/30/2020 | N/A | -4 | -3 | -3 | N/A |
| 3/31/2020 | N/A | -4 | -3 | -3 | N/A |
| 12/31/2019 | N/A | -4 | -3 | -3 | N/A |
| 9/30/2019 | N/A | -4 | -3 | -3 | N/A |
| 6/30/2019 | N/A | -4 | -3 | -3 | N/A |
| 3/31/2019 | N/A | -4 | -3 | -3 | N/A |
| 12/31/2018 | N/A | -3 | -3 | -3 | N/A |
| 9/30/2018 | N/A | -3 | -3 | -3 | N/A |
| 6/30/2018 | N/A | -17 | -4 | -4 | N/A |
| 3/31/2018 | N/A | -17 | -3 | -3 | N/A |
| 12/31/2017 | N/A | -17 | -3 | -3 | N/A |
| 9/30/2017 | N/A | -16 | N/A | -2 | N/A |
| 6/30/2017 | N/A | -1 | N/A | -1 | N/A |
| 3/31/2017 | N/A | -1 | N/A | -1 | N/A |
| 12/31/2016 | N/A | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MNPR is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: MNPR is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: MNPR is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: MNPR is forecast to have no revenue next year.
High Growth Revenue: MNPR is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MNPR's Return on Equity is forecast to be high in 3 years time